Ignite Creation Date:
2025-12-24 @ 10:03 PM
Ignite Modification Date:
2025-12-25 @ 7:39 PM
Study NCT ID:
NCT02143635
Status:
COMPLETED
Last Update Posted:
2021-05-21
First Post:
2014-05-19
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study to Determine and Evaluate a Safe and Tolerated Dose of HDM201 in Patients With Selected Advanced Tumors That Are TP53wt
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-07-07
Start Date Type:
ACTUAL
Primary Completion Date:
2017-06-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-06-09
Completion Date Type:
ACTUAL
First Submit Date:
2014-05-19
First Submit QC Date:
None
Study First Post Date:
2014-05-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-05-20
Last Update Post Date:
2021-05-21
Last Update Post Date Type:
ACTUAL